The approval for the insurance benefit of ‘Nexavar’… the birth of the only treatment of thyroid cancer
.jpg)
‘Nexavar’, a well-known drug for liver cancer, will be permitted to be prescribed for thyroid cancer patients.
After the review of the Cancer Deliberation Committee last month, the Health Insurance Review & Assessment Service recently revised the ‘detailed matters for application standards and m...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
